Show simple item record

dc.contributor.authorSenan, S.en_US
dc.contributor.authorCardenal, F.en_US
dc.contributor.authorVansteenkiste, Jen_US
dc.contributor.authorStigt, Jen_US
dc.contributor.authorAkyol, F.en_US
dc.contributor.authorNeve, W deen_US
dc.contributor.authorBakker, J.en_US
dc.contributor.authorDupont, J.M.en_US
dc.contributor.authorScagliotti, GVen_US
dc.contributor.authorRicardi, U.en_US
dc.contributor.authorMeerbeeck, JP vanen_US
dc.date.accessioned2013-07-10T16:09:02Z
dc.date.available2013-07-10T16:09:02Z
dc.date.issued2011en_US
dc.identifier.citationAnnals of Oncology, 22(3), 553-558en_US
dc.identifier.issn0923-7534
dc.identifier.urihttp://hdl.handle.net/1871/46707
dc.relation.uri10.1093/annonc/mdq388
dc.titleA randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung canceren_US
dc.typeArticle / Letter to editoren_US
dc.creator.metisIdVU1059436
dc.creator.metisIdVU1169689
dc.creator.metisIdVU1063084
dc.creator.metisIdVU1063287
dc.creator.metisIdVU1169690
dc.creator.metisIdVU1087612
dc.creator.metisIdVU1034526
dc.creator.metisIdVU1169691
dc.creator.metisIdVU1067348
dc.creator.metisIdVU1169692
dc.creator.metisIdVU1063329
dc.identifier.metisId281529
dc.provenance.metis2012-02-24 16:50
dc.source.volume22
dc.source.journalTitleAnnals of Oncologyen_US
dc.source.startpage553
dc.source.endpage558
dc.source.issue3
dc.creator.facultyVU medisch centrumnl_NL
dc.coverage.researchinstituteVUmc CCA 04nl_NL
dc.date.updated2014-01-27T23:47:54Z


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record